FDA Warning and Matthew Perry’s Death Darken Ketamines Glow

FDA Warning and Matthew Perry’s Death Darken Ketamines Glow

Byaza slimene

Comment on this storyNote Add to your saved stories Save Federal health authorities are intensifying their scrutiny of the drug ketamine for treating mental health disorders, because the mind-altering compound is growing in popularity despite the lack of regulatory approval for such use. The Food and Drug Administration warned in October about the risks of…

Mass becomes first state to stop asking doctors about past mental illness and drug use – The Boston Globe

Mass becomes first state to stop asking doctors about past mental illness and drug use – The Boston Globe

Byaza slimene

Now, in an effort to combat stigma and burnout among medical professionals, Massachusetts has become the first state to eliminate questions about providers’ mental illness and addiction throughout the health care system. In about two dozen other states, professional boards that license doctors have stopped the practice. After Massachusetts went further: scrubbing the questions from…

End of content

End of content